Lazard Asset Management’s TScan Therapeutics TCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-70
| Closed | – | – | 2575 |
|
|
2024
Q4 | $0 | Hold |
70
| – | – | ﹤0.01% | 2534 |
|
|
2024
Q3 | $0 | Sell |
70
-106
| -60% | – | ﹤0.01% | 2455 |
|
|
2024
Q2 | $0 | Sell |
176
-2,375
| -93% | – | ﹤0.01% | 2427 |
|
|
2024
Q1 | $19K | Sell |
2,551
-1,432
| -36% | -$10.7K | ﹤0.01% | 1846 |
|
|
2023
Q4 | $22K | Buy |
+3,983
| New | +$22K | ﹤0.01% | 2049 |
|